For pharmaceutical products to be imported into India, foreign manufacturers must obtain registration from the Central Drugs Standard Control Organization (CDSCO). The process involves several key steps:
1. Application Submission: The foreign manufacturer or their authorized agent submits an application using Form 40 through the CDSCO's SUGAM portal. This application must include detailed product information, manufacturing details, and quality certifications.
2. Clinical Trial Data: If the product is classified as a new drug or requires clinical evaluation, clinical trial data must be provided to demonstrate safety and efficacy.
3. Manufacturing Site Registration: The manufacturing facility must be registered with CDSCO, ensuring compliance with Good Manufacturing Practices (GMP).
4. Import License: Upon approval, an import license is granted, allowing the product to be imported into India.
The entire process can take several months, depending on the complexity of the product and the completeness of the submitted documentation. It's crucial for foreign manufacturers to work closely with their authorized agents in India to navigate this process effectively.
